Why 3/5: Establishes ongoing reporting and transparency for a critical public health program.
The Department of Health will now be required to maintain a public list of agencies receiving opioid antagonists and submit regular reports on the program's distribution and estimated costs. This enhances transparency and oversight for a state program critical to addressing the opioid crisis and supporting substance-use care in Virginia.
Update
Placed on Calendar
First reading
Read first time
Referred to committee
Referred to Committee on Health and Human Services
Cleared committee
Reported from Health and Human Services (21-Y 0-N)
Second reading
Read second time
Third reading
Read third time
Passed a chamber
Passed House (98-Y 0-N 0-A)
Enrolled
Enrolled
Passed a chamber
Bill text as passed Senate and House (SB706ER)
This bill has passed its votes and is headed to the Governor's desk. You still have a say — the Governor's office reads messages before deciding whether to sign.
New to all this? See how a bill becomes law →
Summarized from the official bill text (“Opioid antagonist; distribution program, reports.”) · Read the actual bill →
Update
Fiscal Impact Statement from Department of Planning and Budget (SB706)
Passed a chamber
Signed by Speaker
Passed a chamber
Signed by President
Enrolled
Enrolled Bill communicated to Governor on March 10, 2026
Sent to the Governor
Governor's Action Deadline 11:59 p.m., April 13, 2026
Line-item veto
Governor's recommendation received by Senate (SB706G)